Vertex Pharmaceuticals’ Casgevy (exagamglogene autotemcel) has continued to show benefits in sickle cell disease (SCD) ...

"BioAtla presents Phase I data of BA3182 for metastatic adenocarcinoma" was originally created and published by Clinical ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

When surgeons dissect tissue to remove a tumor or make a repair, they must work cautiously, relying on electrophysical ...

Brazil is experiencing a regulatory revolution that is fundamentally transforming its medical device clinical trial landscape ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

New diagnostic tools detect diseases at earlier stages while helping doctors personalize treatments. Medical institutions support these breakthrough tests through rigorous clinical trials and ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

Fifty-five percent of the studies demonstrated alternative endpoint ... The researchers suggest that late-phase clinical trial design should focus on OS and QoL improvements to obtain the most valid ...

Thermo Fisher Scientific’s Accelerator™ Drug Development solutions, which integrate services for contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) ...

His experiment laid the foundation for modern clinical trials—structured studies on humans to assess the safety and effectiveness of treatments, vaccines, or preventive interventions.